| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |